THE AUSTRALIA-BASED
GLOBAL CRO FOR BIOTECHS
Avance Clinical is a full-service Contract Research Organization (CRO) headquartered in Australia, with extensive operations across North America, Asia, New Zealand and Europe. With more than 30 years of experience leading Early Phase clinical trials, we leverage the unique advantages of the Australian market, including rapid ethics approval, no IND requirement, and up to 43.5% off with the Australian R&D tax rebate, to provide biotechs with an accelerated pathway to clinical success.
Specializing in world-class operations, we guide biotechs from early pre-clinical development through to late-phase studies. With a focus on agility, innovation, and cost-effectiveness, we deliver fast results backed by robust, globally accepted data.
With expertise spanning over 250+ indications, across all therapeutic areas, over the last three decades, Avance Clinical consistently delivers data recognized by key global regulators, including the TGA, FDA, EMA, MHRA, MFDS, and PDMA.
What sets us apart is our personalized service tailored to each client, ensuring customized, flexible solutions rather than a one-size-fits-all approach.
FROST & SULLIVAN
GLOBAL CRO OF THE YEAR
2026
FROST & SULLIVAN
BIOTECH CRO EXCELLENCE
2025
Early Phase success
From comprehensive pre-clinical consultancy services through to phase one trials, we offer fast, agile and adaptive clinical research solutions for biotechs in the early phases of their drug development.
The ClinicReady team, our inhouse scientific and regulatory affairs experts, lay the vital clinical foundations that ensure seamless and successful transition into phase one and beyond.
Late phase success
Our late phase operations deliver multi-regional clinical excellence across key therapeutic areas including oncology, CNS, rare diseases and infectious diseases. Our global teams apply decades of drug development experience, and leverage the latest technology, including AI and gold standard systems and processes, across all functional areas to deliver an exceptional CRO experience for biotechs.
Solutions
Bringing more than three decades of clinical operations experience.
WHY BIOTECHS
CHOOSE
AVANCE CLINICAL
Avance Clinical’s global teams have a world-class reputation for delivering quality data that is accepted by all the international regulatory authorities including FDA and EMA.
The Avance Clinical Technology & Innovation unit invests heavily in industry-leading as well as emerging technology platforms that elevate quality, speed, and cost metrics for our biotech clients. As part of this technology focus, Avance Clinical also has certified in-house platform specialists including Medidata trained experts.
Avance Clinical is one of the very few mid-sized global CROs with an in-house Scientific and Regulatory Affairs team delivering cross functional streamlined processes, and rapid and cost saving solutions.
Avance Clinical’s Australian operations can deliver Site Initiation Visit (SIV) and Study Start in 5 – 6 weeks. No IND is required. Indeed, more than 280 Phase III global trials conducted their Phase I in Australia. The 43.5% clinical trial rebate program can also extend to multi-regional later phases.
Latest News
Proven industry
experience & expertise
500+
Studies in the past 5 years
450+
Experienced team members
18k+
Participants past 5 years
30
Years of CRO experience